HEMOLYTIC
ANEMIA
PRESENTER – DR PREETI UTNAL
MODERATOR - DR MANJULA K
OBJECTIVES
 Definition
 Classification
 Etiology
 Evaluation of hemolytic anemia
 References
DEFINITION
 Hemolytic disorders are characterised by signs of
accelerated erythrocyte destruction together with those of
vigorous blood regeneration.
 Shortened life span of RBC’s – 15-20 days.
 Elevated Erythropoietin
 Accumulation of haemoglobin degradation products.
CLASSIFICATION OF HEMOLYTIC
ANAEMIA
INTRINSIC EXTRINSIC
CONGENITAL ACQUIRED
MEMBRANE
DISORDER
HEMOGLOBINOPATHIES
ENZYME
DISORDERS
PNH
IMMUNE
DRUG INDUCED
NON-IMMUNE
AUTO Ab ALLO Ab
SITE OF RBC
DESTRUCTION Intravascular
Red cells rupture within the vasculature releasing free
hemoglobin into circulation
 Extravascular
 Liver
 Spleen
 Bone marrow
Splenomegaly is a feature of
extravascular helmolysis
Causes of extravascular
hemolysis
Pathogenesis of Extra vascular hemolysis
 Extreme changes in shape required for RBC to navigate the splenic
sinusoids successfully
This alterations result in to less deformable RBC
RBC sequestration & phagocytosis by Macrophages located within splenic cords
Globin
Protein pool
Haem
Biliverdin Bilirubin
Unconjugated bilirubin
Conjugated bilrubin
Urobilinogen
Excretion in Faeces & urine and
formation of gall stones
Causes of intravascular hemolysis
 Mechanical injury
 Complement fixation
 Intracellular parasite
 Exogenous toxic factors
General consideration in the
diagnosis of hemolytic anemia
 Is the anemia hemolytic ?
 If so, is it Intravascular / Extravascular haemolysis?
 What is the etiology?
 What is the severity of anemia?
IS THE ANEMIA HAEMOLYTIC?
Evidence for increased red cell
production-
IN BLOOD - peripheral smear
1.Increased reticulocyte count
2.Circulating nucleated RBC
3.Marked polychromasia.
 Polychromatophilic red cells(A--green arrows)
 Spherocytes (B--blue arrows)
 Nucleated red blood cells (D-- orange arrow)
Fragmented cells, spherocytes, blister cells and
punctate basophilia
Reticulocytosis
BONE MARROW BIOPSY
ERYTHROID
HYPERPLASIA
INVESTIGATION
OF MEMBRANE
DEFECT
HEREDITARY
SHPEROCYTOSIS
PATHOPHYSIOLOGY OF HS
Primary membrane skeletal defect
Membrane stability
Membrane loss
Surface to volume ratio
deformability
Splenic trapping
Erythrostasis
Glucose pH
phagocytosis
Lab Findings
 Minimal / no anemia
 Spherocytes
 Polychromasia
 MCV , MCHC
 Negative antiglobulin test
Polychromatic cell
Spherocyte
Special tests done
1. OSMOTIC FRAGILITY TEST
 Measure of the erythrocytes resistance to hemolysis
by osmotic stress.
OSMOTIC FRAGILITY
TEST
NORMAL
ABNORMAL
INCREASED IN
• H.Spherocytosis
• H.Elliptocytosis
• H.stomatocytosis
• AI Hemolytic anemia.
DECREASED IN
• Thalassemia
• Iron deficiency anemia.
OSMOTIC FRAGILITY
TEST Shift to left – increased OF
Shift to right – decreased OF
INCUBATED OSMOTIC
FRAGILITY TEST
 Blood incubated for 24hrs
 At 37°C HS cells lose membranes more readily then
normal RBC’s when incubated
 Increased sensitivity
 Most reliable diagnostic test for HS
AUTOHEMOLYSIS TEST
 Measures spontaneous hemolysis of blood incubated
at 37ºc for 48 hrs
 Measure readings colorimetrically at 540nm
 Normal – 0.2-2 %
 With added glucose – 0-0.9 %
Decreased rate with added Glucose
Hereditary Spherocytosis
PNH
G6PD Deficiency
No response to added glucose
Pyruvate Kinase Deficiency
ACIDIFIED GLYCEROL LYSIS
TIME Time taken for 50% hemolysis of a blood sample in a
buffered hypotonic saline glycerol mixture.
 Glycerol retards the osmotic swelling of red cells
 Rate of hemolysis is measured by rate of fall of
turbidity
 Half time for AGLT > 30min for normal RBC’s
 HS cells 25-150 sec
CRYOHEMOLYSIS
 Specific for Hereditary Spherocytosis
 Dependent on molecular defects of RBC membrane.
 HS cells are particularly sensitive to cooling at 0 °C in
hypertonic saline.
 Normal: 3 – 15%
 HS - >20%
HERIDITARY ELLIPTOCYTOSIS
INVESTIGATIONS OF
HEMOGLOBINOPATHIE
S
THALASSEMIA
 Autosomal dominant
 Reduced synthesis of normal Hb polypeptide
chain due to molecular defects.
 Hematologic consequences:
 Low intracellular Hb
 Relative excess of unpaired chain
Pathogenesis
 Imbalanced synthesis of α & β chains
 Decreased total RBC Hb production
 Ineffective erythropoiesis
 Chronic hemolytic process
 Systemic iron overload
THALASSAEMIA
LAB FINDINGS
 Microcytic Hypochromic anemia(2-3g/dl)
 Decreased MCV , MCH , MCHC
 Decreased Osmotic Fragility.
 Increased serum uric acid
 Anisopoikilocytosis
Lab Findings- BM
 Normoblastic
erythroid hyperplasia
 Increased
macrophages
 Inclusion bodies in
normoblasts
SICKLE CELL ANAEMIA
 Hereditary disorder – autosomal recessive
 RBC contains Hb S
 α2β2
6GLU ↔ VAL
 Hypoxia , acidosis, hypertonicity, ↑temp→ deoxygenation
→ Hb S polymerisation → sickle cells
SICKLE CELL ANAEMIA
• Normocytic normochromic
anemia
• Sickle cells
• Reticulocytosis ( 10 – 20 %)
• Anisopoikilocytsis
• Howell jolly bodies
• Normoblast
• ↑RDW
• BM – Erythroid hyperplasia
SOLUBILITY TEST
 Sickle cell Hb is insoluble in
deoxygenated state in a high
molality phosphate buffer
 Crystals formed refract light,
cause solution to be turbid.
 Positive test – sickling Hb
 Doesn’t differentiate b/w
homozygous & heterozygous
POSITIVE TEST
SICKLING TEST
 Blood deoxygenated with
reducing substances (sodium
metabisulphite)
 Place on slide
 Seal coverslip
 Immediate sickling – Disease
 Sickling in 1 hr – Trait
1. Hb electrophoresis
2. High performance liquid
Chromatography (HPCL)
3. Isoelectric focusing – agar
gel
4. Prenatal diagnosis - PCR
OTHER DIAGNOSTIC
TESTS
INVESTIGATION
OF ENZYME
DEFICIENCY
G6PD DEFICIENCY
 INTRODUCTION
1. Its an enzyme of HMP pathway
2. Protects against oxidative stress
3. X linked disorder
4. Deficiency result in to,
 Impaired NADPH production
 Accumulation of oxidants in cell
 Oxidative stress leads to Heinz body formation & extra-
vascular hemolysis
BLOOD SMEAR IN G6PD DEFICIENCY
FLORESCENT SPOT TEST
 Sensitive screening test
 Whole blood + G6P + NADP + SAPONIN
 Kept on a filter paper
 Examine under UV light
 Examine the Fluorescence
 G6P + NADP 6-Phosphogluconate + NADPH
(Fluoresces)
 Lack of fluorescence ------- G6PD Deficiency
DYE REDUCTION TEST
 Pts blood hemolysate + G6P + NADP + brilliant
cresyl blue ------ incubation
 If G6PD present ----- NADP → NADPH
BLUE → COLOURLESS
 Time taken is inversely proportional to the amt. of
G6PD present
 Controls- normal blood
 Specific test

OTHER TESTS
 ASCORBATE CYANIDE TEST
 METHEMOGLOBIN REDUCTION TEST
 G6PD ASSAY
 Glutathione stability test-Decrease sensitivity in G6PD deficiency.
 PCR-To reveal genetic abnormality(Florescent labelled probes are
used to detect mutant G6PD alleles)
ACQUIRED
HEMOLYTIC ANEMIA
PAROXYSMAL NOCTURNAL
HEMOGLOBINURIA
 Acquired Clonal cell disorder
 Somatic mutation in hematopoietic stem cell.
 Defect in glycosyl – phosphatidyl inositol (GPI) molecule embedded in cell
membrane
 GPI linked proteins – decay accelerating factor (CD 55), Inhibitor of
reactive lysis(CD 59)-Prevents activation of complement.
LAB FINDINGS
 Anemia
 Thrombocytopenia
 Hemosiderinuria
 Positive sucrose hemolysis test
 Positive Ham’s test
 Normal Osmotic fragility
SUCROSE HEMOLYSIS
TEST
 Screening test
 Patient’s blood incubated in sucrose solution
 Sucrose promotes binding of complement to
RBC
 Hemolysis
HAM’S TEST(Acidified
serum lysis test)
 Patient’s RBCs are exposed at 37°C to action of
normal / patient own serum suitably acidified to
optimal pH for lysis( activate alternate pathway)
 10 – 50 % of total RBC ----Lysis
FLOW CYTOMETRY
IMMUNE
MEDIATED
HEMOLYTIC
ANEMIA
PATHOPHYSIOLOGY
RBC’s + IgG Ab
Pass through the spleen
Fc receptor of spleen macrophages attracts
Fc portion of Ab – RBC complex
Phagocytosis of RBC by macrophage
Fragmentation of
RBC membrane
Membrane reseals and
forms spherocytes
Extravascular hemolysis
Indications
INDIRECT ANTIGLOBULIN
TEST
Positive test
1. Isoimmunisation
2. Presence of free auto Ab in patient’s
serum
WARM AIHA
 Individuals produce Ab against their own erythrocyte Ag
(autoantibodies)
 Ab react with red cell Ag best at 37oc.
Lab findings
PBS – Normocytic normochromic anemia
- Reticulocytosis
- Spherocytes,
- Schistocytes, Polychromasia, NRBC’s
- Neutrophilia
- Platelet - normal or decreased
 Bone marrow
- Normoblastic erythroid hyperplasia
- Erythrophagocytosis
 Other tests
- Direct Coombs’ test (DAT)- positive
COLD AIHA
 Associated with IgM Ab which fixes complement & is reactive
below 32o c
 First indication of the presence of unsuspected cold agglutinins
is blood counts.
1. RBC count is inappropriately decreased for Hb%
2. MCV is falsely elevated (due to agglutination)
3. PCV is falsely low
4. MCH & MCHC are falsely elevated
• Visible autoagglutination can be observed in tubes of
anticoagulated blood as the blood cools to room
temperature.
When RBC indices go haywire think of the
possibility of cold agglutinin disease
PAROXYSMAL COLD
HEMOGLOBINURIA
 Lab findings
a) Between the attacks - peripheral blood is normal except for
anemia
b) During the attack – sharp drop in Hb
c)DAT – weakly +ve with anticomplement antisera
- Ab are not detected
d) Indirect coomb’s test may be +ve ,if performed in cold
e) Donath – Landsteiner test
DONATH LANDSTEINER(D-L)
Test
PATIENT’S WHOLE
BLOOD
CONTROL TEST
INCUBATE FOR 30
MIN AT
370 C 40 C
INCUBATE FOR 30
MIN AT
370 C 370 C
Centrifuge: Observe plasma for presence of hemolysis
Interpretation
D-L antibodies present No hemolysis Hemolysis
NO D-L antibodies
present
No hemolysis No hemolysis
AUTOIMMUNE HEMOLYTIC
ANEMIA
 Hemolytic anemia induced by immunization of an
individual with RBC Ag’s from another individual
.
Eg: 1. Hemolytic transfusion reactions
2. Hemolytic disease of new born
DRUG INDUCED AIHA
 It is the result of an immune mediated hemolysis precipitated by
ingestion of certain drugs.
 MECHANISM:
1. Drug adsorption (hapten type)
2. Immune complex formation
3. Autoantibody induction
4. Membrane modification
Haemolytic uremic syndrome
MALARIA
Other conditions where
hemolysis is seen
 Disseminated malignancy
 Leukemia
 Malignant lymphomas
 Renal failure
 Liver disease
 Rheumatoid arthritis
 Megaloblastic anemia
Diagnostic approach
REFERENCE
 Henry’s Clinical diagnosis & Management by Lab. Methods
 Shirlyn B. Mc Kenzie, Text book of Haemotology
 Wintrobe
 Dacie & Lewis, Practical Haematology
 de Gruchy’s clinical Haematology 5th edition, pages 137-210.
THANK YOU

Haemolytic anemia

  • 1.
    HEMOLYTIC ANEMIA PRESENTER – DRPREETI UTNAL MODERATOR - DR MANJULA K
  • 2.
    OBJECTIVES  Definition  Classification Etiology  Evaluation of hemolytic anemia  References
  • 3.
    DEFINITION  Hemolytic disordersare characterised by signs of accelerated erythrocyte destruction together with those of vigorous blood regeneration.  Shortened life span of RBC’s – 15-20 days.  Elevated Erythropoietin  Accumulation of haemoglobin degradation products.
  • 4.
    CLASSIFICATION OF HEMOLYTIC ANAEMIA INTRINSICEXTRINSIC CONGENITAL ACQUIRED MEMBRANE DISORDER HEMOGLOBINOPATHIES ENZYME DISORDERS PNH IMMUNE DRUG INDUCED NON-IMMUNE AUTO Ab ALLO Ab
  • 5.
    SITE OF RBC DESTRUCTIONIntravascular Red cells rupture within the vasculature releasing free hemoglobin into circulation  Extravascular  Liver  Spleen  Bone marrow Splenomegaly is a feature of extravascular helmolysis
  • 6.
  • 8.
    Pathogenesis of Extravascular hemolysis  Extreme changes in shape required for RBC to navigate the splenic sinusoids successfully This alterations result in to less deformable RBC RBC sequestration & phagocytosis by Macrophages located within splenic cords Globin Protein pool Haem Biliverdin Bilirubin Unconjugated bilirubin Conjugated bilrubin Urobilinogen Excretion in Faeces & urine and formation of gall stones
  • 9.
    Causes of intravascularhemolysis  Mechanical injury  Complement fixation  Intracellular parasite  Exogenous toxic factors
  • 12.
    General consideration inthe diagnosis of hemolytic anemia  Is the anemia hemolytic ?  If so, is it Intravascular / Extravascular haemolysis?  What is the etiology?  What is the severity of anemia?
  • 13.
    IS THE ANEMIAHAEMOLYTIC? Evidence for increased red cell production- IN BLOOD - peripheral smear 1.Increased reticulocyte count 2.Circulating nucleated RBC 3.Marked polychromasia.
  • 14.
     Polychromatophilic redcells(A--green arrows)  Spherocytes (B--blue arrows)  Nucleated red blood cells (D-- orange arrow)
  • 15.
    Fragmented cells, spherocytes,blister cells and punctate basophilia
  • 16.
  • 18.
  • 19.
  • 20.
  • 21.
    PATHOPHYSIOLOGY OF HS Primarymembrane skeletal defect Membrane stability Membrane loss Surface to volume ratio deformability Splenic trapping Erythrostasis Glucose pH phagocytosis
  • 22.
    Lab Findings  Minimal/ no anemia  Spherocytes  Polychromasia  MCV , MCHC  Negative antiglobulin test Polychromatic cell Spherocyte
  • 23.
    Special tests done 1.OSMOTIC FRAGILITY TEST  Measure of the erythrocytes resistance to hemolysis by osmotic stress.
  • 24.
    OSMOTIC FRAGILITY TEST NORMAL ABNORMAL INCREASED IN •H.Spherocytosis • H.Elliptocytosis • H.stomatocytosis • AI Hemolytic anemia. DECREASED IN • Thalassemia • Iron deficiency anemia.
  • 25.
    OSMOTIC FRAGILITY TEST Shiftto left – increased OF Shift to right – decreased OF
  • 26.
    INCUBATED OSMOTIC FRAGILITY TEST Blood incubated for 24hrs  At 37°C HS cells lose membranes more readily then normal RBC’s when incubated  Increased sensitivity  Most reliable diagnostic test for HS
  • 27.
    AUTOHEMOLYSIS TEST  Measuresspontaneous hemolysis of blood incubated at 37ºc for 48 hrs  Measure readings colorimetrically at 540nm  Normal – 0.2-2 %  With added glucose – 0-0.9 %
  • 28.
    Decreased rate withadded Glucose Hereditary Spherocytosis PNH G6PD Deficiency No response to added glucose Pyruvate Kinase Deficiency
  • 29.
    ACIDIFIED GLYCEROL LYSIS TIMETime taken for 50% hemolysis of a blood sample in a buffered hypotonic saline glycerol mixture.  Glycerol retards the osmotic swelling of red cells  Rate of hemolysis is measured by rate of fall of turbidity  Half time for AGLT > 30min for normal RBC’s  HS cells 25-150 sec
  • 30.
    CRYOHEMOLYSIS  Specific forHereditary Spherocytosis  Dependent on molecular defects of RBC membrane.  HS cells are particularly sensitive to cooling at 0 °C in hypertonic saline.  Normal: 3 – 15%  HS - >20%
  • 31.
  • 32.
  • 33.
    THALASSEMIA  Autosomal dominant Reduced synthesis of normal Hb polypeptide chain due to molecular defects.  Hematologic consequences:  Low intracellular Hb  Relative excess of unpaired chain
  • 34.
    Pathogenesis  Imbalanced synthesisof α & β chains  Decreased total RBC Hb production  Ineffective erythropoiesis  Chronic hemolytic process  Systemic iron overload
  • 35.
  • 36.
    LAB FINDINGS  MicrocyticHypochromic anemia(2-3g/dl)  Decreased MCV , MCH , MCHC  Decreased Osmotic Fragility.  Increased serum uric acid  Anisopoikilocytosis
  • 37.
    Lab Findings- BM Normoblastic erythroid hyperplasia  Increased macrophages  Inclusion bodies in normoblasts
  • 39.
    SICKLE CELL ANAEMIA Hereditary disorder – autosomal recessive  RBC contains Hb S  α2β2 6GLU ↔ VAL  Hypoxia , acidosis, hypertonicity, ↑temp→ deoxygenation → Hb S polymerisation → sickle cells
  • 40.
    SICKLE CELL ANAEMIA •Normocytic normochromic anemia • Sickle cells • Reticulocytosis ( 10 – 20 %) • Anisopoikilocytsis • Howell jolly bodies • Normoblast • ↑RDW • BM – Erythroid hyperplasia
  • 41.
    SOLUBILITY TEST  Sicklecell Hb is insoluble in deoxygenated state in a high molality phosphate buffer  Crystals formed refract light, cause solution to be turbid.  Positive test – sickling Hb  Doesn’t differentiate b/w homozygous & heterozygous POSITIVE TEST
  • 42.
    SICKLING TEST  Blooddeoxygenated with reducing substances (sodium metabisulphite)  Place on slide  Seal coverslip  Immediate sickling – Disease  Sickling in 1 hr – Trait 1. Hb electrophoresis 2. High performance liquid Chromatography (HPCL) 3. Isoelectric focusing – agar gel 4. Prenatal diagnosis - PCR OTHER DIAGNOSTIC TESTS
  • 43.
  • 44.
    G6PD DEFICIENCY  INTRODUCTION 1.Its an enzyme of HMP pathway 2. Protects against oxidative stress 3. X linked disorder 4. Deficiency result in to,  Impaired NADPH production  Accumulation of oxidants in cell  Oxidative stress leads to Heinz body formation & extra- vascular hemolysis
  • 45.
    BLOOD SMEAR ING6PD DEFICIENCY
  • 46.
    FLORESCENT SPOT TEST Sensitive screening test  Whole blood + G6P + NADP + SAPONIN  Kept on a filter paper  Examine under UV light  Examine the Fluorescence  G6P + NADP 6-Phosphogluconate + NADPH (Fluoresces)  Lack of fluorescence ------- G6PD Deficiency
  • 47.
    DYE REDUCTION TEST Pts blood hemolysate + G6P + NADP + brilliant cresyl blue ------ incubation  If G6PD present ----- NADP → NADPH BLUE → COLOURLESS  Time taken is inversely proportional to the amt. of G6PD present  Controls- normal blood  Specific test 
  • 48.
    OTHER TESTS  ASCORBATECYANIDE TEST  METHEMOGLOBIN REDUCTION TEST  G6PD ASSAY  Glutathione stability test-Decrease sensitivity in G6PD deficiency.  PCR-To reveal genetic abnormality(Florescent labelled probes are used to detect mutant G6PD alleles)
  • 49.
  • 50.
    PAROXYSMAL NOCTURNAL HEMOGLOBINURIA  AcquiredClonal cell disorder  Somatic mutation in hematopoietic stem cell.  Defect in glycosyl – phosphatidyl inositol (GPI) molecule embedded in cell membrane  GPI linked proteins – decay accelerating factor (CD 55), Inhibitor of reactive lysis(CD 59)-Prevents activation of complement.
  • 51.
    LAB FINDINGS  Anemia Thrombocytopenia  Hemosiderinuria  Positive sucrose hemolysis test  Positive Ham’s test  Normal Osmotic fragility
  • 52.
    SUCROSE HEMOLYSIS TEST  Screeningtest  Patient’s blood incubated in sucrose solution  Sucrose promotes binding of complement to RBC  Hemolysis
  • 53.
    HAM’S TEST(Acidified serum lysistest)  Patient’s RBCs are exposed at 37°C to action of normal / patient own serum suitably acidified to optimal pH for lysis( activate alternate pathway)  10 – 50 % of total RBC ----Lysis
  • 54.
  • 55.
  • 56.
    PATHOPHYSIOLOGY RBC’s + IgGAb Pass through the spleen Fc receptor of spleen macrophages attracts Fc portion of Ab – RBC complex Phagocytosis of RBC by macrophage Fragmentation of RBC membrane Membrane reseals and forms spherocytes Extravascular hemolysis
  • 58.
  • 59.
  • 60.
    Positive test 1. Isoimmunisation 2.Presence of free auto Ab in patient’s serum
  • 61.
    WARM AIHA  Individualsproduce Ab against their own erythrocyte Ag (autoantibodies)  Ab react with red cell Ag best at 37oc. Lab findings PBS – Normocytic normochromic anemia - Reticulocytosis - Spherocytes, - Schistocytes, Polychromasia, NRBC’s - Neutrophilia - Platelet - normal or decreased
  • 62.
     Bone marrow -Normoblastic erythroid hyperplasia - Erythrophagocytosis  Other tests - Direct Coombs’ test (DAT)- positive
  • 63.
    COLD AIHA  Associatedwith IgM Ab which fixes complement & is reactive below 32o c  First indication of the presence of unsuspected cold agglutinins is blood counts. 1. RBC count is inappropriately decreased for Hb% 2. MCV is falsely elevated (due to agglutination) 3. PCV is falsely low 4. MCH & MCHC are falsely elevated • Visible autoagglutination can be observed in tubes of anticoagulated blood as the blood cools to room temperature.
  • 64.
    When RBC indicesgo haywire think of the possibility of cold agglutinin disease
  • 65.
    PAROXYSMAL COLD HEMOGLOBINURIA  Labfindings a) Between the attacks - peripheral blood is normal except for anemia b) During the attack – sharp drop in Hb c)DAT – weakly +ve with anticomplement antisera - Ab are not detected d) Indirect coomb’s test may be +ve ,if performed in cold e) Donath – Landsteiner test
  • 66.
    DONATH LANDSTEINER(D-L) Test PATIENT’S WHOLE BLOOD CONTROLTEST INCUBATE FOR 30 MIN AT 370 C 40 C INCUBATE FOR 30 MIN AT 370 C 370 C Centrifuge: Observe plasma for presence of hemolysis Interpretation D-L antibodies present No hemolysis Hemolysis NO D-L antibodies present No hemolysis No hemolysis
  • 67.
    AUTOIMMUNE HEMOLYTIC ANEMIA  Hemolyticanemia induced by immunization of an individual with RBC Ag’s from another individual . Eg: 1. Hemolytic transfusion reactions 2. Hemolytic disease of new born
  • 68.
    DRUG INDUCED AIHA It is the result of an immune mediated hemolysis precipitated by ingestion of certain drugs.  MECHANISM: 1. Drug adsorption (hapten type) 2. Immune complex formation 3. Autoantibody induction 4. Membrane modification
  • 69.
  • 70.
  • 71.
    Other conditions where hemolysisis seen  Disseminated malignancy  Leukemia  Malignant lymphomas  Renal failure  Liver disease  Rheumatoid arthritis  Megaloblastic anemia
  • 72.
  • 74.
    REFERENCE  Henry’s Clinicaldiagnosis & Management by Lab. Methods  Shirlyn B. Mc Kenzie, Text book of Haemotology  Wintrobe  Dacie & Lewis, Practical Haematology  de Gruchy’s clinical Haematology 5th edition, pages 137-210.
  • 75.

Editor's Notes

  • #16 Fragmented cells, spherocytes, blister cells and punctate basophilia blood film of a patient with Pyruvate Kinase Deficiency? Thorny Apple sputnik cells, polychromasia
  • #17 Reticulocytosis
  • #46 Blister cells (arrows) Heinz bodies 9new methylene blue stain) (Inset)
  • #47 False normal-Reticulocytosis,False deficient-anemia
  • #59 Differential diagnosis for causes of intravascular hemolysis resulting in a positive DAT. DAT = direct antiglobulin test; PCH = paroxysmal cold hemoglobinuria; WAHA = warm autoimmune hemolytic anemia; MT-AIHA = mixed-type autoimmune hemolytic anemia; CAS = cold agglutinin syndrome.
  • #65 When RBC indices go haywire think of the possibility of cold agglutinin disease
  • #71 Falciparum malaria Pl.vivax